Collplant Biotechnologies Ltd (CLGN) — Cash Flow Quality Index

Latest as of June 2023: -0.65x

Collplant Biotechnologies Ltd (CLGN) has a Cash Flow Quality Index of -0.65x as of June 2023. Operating cash flow of $-3.74 Million is below net income of $5.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Collplant Biotechnologies Ltd (CLGN) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.65x
Operating CF / Net Income

Operating Cash Flow

$-3.74 Million
USD

Net Income

$5.76 Million
USD

Data as of

Jun 2023
Most recent filing

Collplant Biotechnologies Ltd Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Collplant Biotechnologies Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Collplant Biotechnologies Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Collplant Biotechnologies Ltd (2021–2021)

Year-by-year earnings quality comparison for Collplant Biotechnologies Ltd. For live market cap and the full company financial profile, see market cap of Collplant Biotechnologies Ltd.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 10.55x $2.50 Million $237.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.